79 related articles for article (PubMed ID: 11892609)
1. Use of tenofovir.
AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892609
[No Abstract] [Full Text] [Related]
2. FDA approves tenofovir.
AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892608
[No Abstract] [Full Text] [Related]
3. Promising results for tenofovir.
AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
[No Abstract] [Full Text] [Related]
4. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
[No Abstract] [Full Text] [Related]
5. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon.
Eagan L
Posit Living; 2001; 10(5):21. PubMed ID: 11693102
[No Abstract] [Full Text] [Related]
6. Tenofovir--long term results from first-line therapy.
TreatmentUpdate; 2003; 15(2):4-6. PubMed ID: 12693361
[No Abstract] [Full Text] [Related]
7. Tenofovir DF trial announced by Gilead.
Eagan L
Posit Living; 2000 Jul; 9(6):22, 54. PubMed ID: 12492018
[No Abstract] [Full Text] [Related]
8. [Tenofovir (Viread)].
Sidahora; 2002; (1):20-1. PubMed ID: 12772661
[No Abstract] [Full Text] [Related]
9. More uses for tenofovir?
AIDS Treat News; 2001 Jan; (377):4. PubMed ID: 11862808
[No Abstract] [Full Text] [Related]
10. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
MMW Fortschr Med; 2002 Aug; 144(33-34):60-1. PubMed ID: 12380157
[No Abstract] [Full Text] [Related]
11. Tenofovir helps experienced patients.
AIDS Patient Care STDS; 2002 Mar; 16(3):136. PubMed ID: 11951839
[No Abstract] [Full Text] [Related]
12. Prevention trials starting.
AIDS Patient Care STDS; 2004 Jun; 18(6):366-7. PubMed ID: 15384199
[No Abstract] [Full Text] [Related]
13. High rate of virologic failure with once-daily ddI/3TC/TDF.
IAPAC Mon; 2003 Nov; 9(11):279. PubMed ID: 14989185
[No Abstract] [Full Text] [Related]
14. Tenofovir: FDA hearing on important new antiretroviral.
James JS
AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411
[No Abstract] [Full Text] [Related]
15. Cambodia stops important tenofovir prevention trial.
James JS
AIDS Treat News; 2004 Jul; (403):4-5. PubMed ID: 15386853
[TBL] [Abstract][Full Text] [Related]
16. French investigators warn of LPV/TDF/ddI interaction.
Carter M
IAPAC Mon; 2003 Dec; 9(12):315. PubMed ID: 15055164
[No Abstract] [Full Text] [Related]
17. Tenofovir drug interactions: ddI and d4T.
TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
[No Abstract] [Full Text] [Related]
18. Tenofovir (Viread(R)) access for poor countries.
James JS
AIDS Treat News; 2002 Dec; (386):6-7. PubMed ID: 12569875
[TBL] [Abstract][Full Text] [Related]
19. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
van Bömmel F; Wünsche T; Schürmann D; Berg T
Hepatology; 2002 Aug; 36(2):507-8. PubMed ID: 12143063
[No Abstract] [Full Text] [Related]
20. Tenofovir approved: broad indication.
James JS
AIDS Treat News; 2001 Oct; (373):2-3. PubMed ID: 11768879
[No Abstract] [Full Text] [Related]
[Next] [New Search]
